Sandoz Group AG (MEX:SDZN) Common Stock: MXN436 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:SDZN Sandoz Group AG MEX:SDZN
27 GF Score
Price MXN1,481.70
GF Value MXN988.01
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Common Stock?

Sandoz Group AG MEX:SDZN 27 Common Stock is MXN436 Mil as of Jun. 2026. GuruFocus rates MEX:SDZN with a GF Score™ of 27/100 and a GF Value™ of MXN988.01. The stock has 6 warning signs investors should review.

Sandoz Group AG's quarterly common stock declined from Jun. 2025 (MXN471 Mil) to Dec. 2025 (MXN450 Mil) and declined from Dec. 2025 (MXN450 Mil) to Jun. 2026 (MXN436 Mil).

Sandoz Group AG's annual common stock increased from Dec. 2023 (MXN407 Mil) to Dec. 2024 (MXN521 Mil) but then declined from Dec. 2024 (MXN521 Mil) to Dec. 2025 (MXN450 Mil).

Sandoz Group AG Common Stock Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Common Stock Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
170,551.01 407.38 521.39 450.14

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Common Stock Get a 7-Day Free Trial 439.68 521.39 470.73 450.14 436.23
MEX:SDZN
27GF Score
Sandoz Group AG MEX:SDZN
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of MXN436 Mil mean?
Sandoz Group AG (MEX:SDZN) has a Common Stock of MXN436 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Common Stock too high?
Sandoz Group AG's current Common Stock is MXN436 Mil. Overall, Sandoz Group AG has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Common Stock compare to ZTS and UTHR?
Sandoz Group AG's Common Stock of MXN436 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Common Stock is MXN436 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (MEX:SDZN) has a current Common Stock of MXN436 Mil. The stock's GF Value™ is MXN988.01, compared to a current price of MXN1,481.70 — trading 50% above its estimated fair value. The current Common Stock is MXN436 Mil. Sandoz Group AG's overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Sandoz Group AG (MEX:SDZN), the current Common Stock is MXN436 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sandoz Group AG (MEX:SDZN) Overvalued in 2026?

Based on GuruFocus' analysis, Sandoz Group AG stock appears to be overvalued. The current stock price of MXN1,481.70 is trading 50% above its estimated GF Value™ of MXN988.01.

Key valuation signals for MEX:SDZN:

  • Common Stock: MXN436 Mil
  • GF Value™: MXN988.01 vs. price of MXN1,481.70 (50% above fair value)
  • GF Score™: 27/100 with 6 warning signs

No single metric tells the full story. See the MEX:SDZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
27GF Score

Get the complete analysis for MEX:SDZN

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,481.70
Price
MXN988.01
GF Value